A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Clinical trial NCT06405087 · RECRUITING

Trial details

NCT number: NCT06405087
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis Crohn's Disease

Start date: 2025-10-27
Primary completion: 2030-08-12
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.